Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
A Phase I Clinical, Pharmacokinetic, And Pharmacodynamic Evaluation Of 2 Schedules Of Oral PD 0332991, A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
Status: Enrolling
Updated:  12/3/2015
Abramson Cancer Center, Hospital of the Univ. of Pennsylvania
mi
from
Philadelphia, PA
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
A Phase I Clinical, Pharmacokinetic, And Pharmacodynamic Evaluation Of 2 Schedules Of Oral PD 0332991, A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
Status: Enrolling
Updated: 12/3/2015
Abramson Cancer Center, Hospital of the Univ. of Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
A Phase I Clinical, Pharmacokinetic, And Pharmacodynamic Evaluation Of 2 Schedules Of Oral PD 0332991, A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
Status: Enrolling
Updated:  12/3/2015
Pharmacy/PCAM/West Pavillion
mi
from
Philadelphia, PA
A Study Of Oral Palbociclib (PD-0332991), A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
A Phase I Clinical, Pharmacokinetic, And Pharmacodynamic Evaluation Of 2 Schedules Of Oral PD 0332991, A Cyclin-Dependent Kinase Inhibitor, In Patients With Advanced Cancer
Status: Enrolling
Updated: 12/3/2015
Pharmacy/PCAM/West Pavillion
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated:  12/3/2015
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated: 12/3/2015
Walter Reed National Military Medical Center
mi
from
Bethesda, MD
Click here to add this to my saved trials
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated:  12/3/2015
Ann Arbor VA Healthcare System
mi
from
Ann Arbor, MI
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated: 12/3/2015
Ann Arbor VA Healthcare System
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated:  12/3/2015
University of Michigan
mi
from
Ann Arbor, MI
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated: 12/3/2015
University of Michigan
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated:  12/3/2015
John D. Dingell VA Medical Center
mi
from
Detroit, MI
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated: 12/3/2015
John D. Dingell VA Medical Center
mi
from
Detroit, MI
Click here to add this to my saved trials
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated:  12/3/2015
Durham VA Medical Center
mi
from
Durham, NC
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated: 12/3/2015
Durham VA Medical Center
mi
from
Durham, NC
Click here to add this to my saved trials
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated:  12/3/2015
Huron Gastro
mi
from
Ypsilanti, MI
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Prevalence and Topography of Adenomas in 40-49 Year Old Patients With a Family History of Colon Cancer
Status: Enrolling
Updated: 12/3/2015
Huron Gastro
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated:  12/3/2015
Pinnacle Research Group, LLC
mi
from
Anniston, AL
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated: 12/3/2015
Pinnacle Research Group, LLC
mi
from
Anniston, AL
Click here to add this to my saved trials
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated:  12/3/2015
Indianapolis Gastroenterology & Hepatology, Inc.
mi
from
Indianapolis, IN
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated: 12/3/2015
Indianapolis Gastroenterology & Hepatology, Inc.
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated:  12/3/2015
Dayton Gastroenterology, Inc.
mi
from
Dayton, OH
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated: 12/3/2015
Dayton Gastroenterology, Inc.
mi
from
Dayton, OH
Click here to add this to my saved trials
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated:  12/3/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated: 12/3/2015
Thomas Jefferson University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated:  12/3/2015
Franklin Gastroenterology
mi
from
Franklin, TN
Optimization of the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
MA-205 / COVGIC20482: A Multicenter, Consecutive, Randomized Study to Optimize the Bowel Preparation Regimen for the PillCam COLON 2 Capsule Endoscopy Procedure
Status: Enrolling
Updated: 12/3/2015
Franklin Gastroenterology
mi
from
Franklin, TN
Click here to add this to my saved trials
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
A Phase IIb Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topical Bacteriophage T4 Endonuclease V in Renal Allograft Recipients With a History of Non-melanoma Skin Cancer
Status: Enrolling
Updated:  12/3/2015
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
T4N5 Liposomal Lotion in Preventing The Recurrence of Nonmelanoma Skin Cancer in Patients Who Have Undergone a Kidney Transplant
A Phase IIb Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topical Bacteriophage T4 Endonuclease V in Renal Allograft Recipients With a History of Non-melanoma Skin Cancer
Status: Enrolling
Updated: 12/3/2015
UAB Comprehensive Cancer Center
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)
Status: Enrolling
Updated:  12/3/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)
A Phase II Study of AZD2171 in Breast Cancer Stage IV (10006202)
Status: Enrolling
Updated: 12/3/2015
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
City of Hope
mi
from
Duarte, CA
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
City of Hope
mi
from
Duarte, CA
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
University of Southern California
mi
from
Los Angeles, CA
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
University of Southern California
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
UC Davis Comprehensive Cancer Center
mi
from
Sacramento, CA
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
UC Davis Comprehensive Cancer Center
mi
from
Sacramento, CA
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
University of Chicago Comprehensive Cancer Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
Evanston CCOP-NorthShore University HealthSystem
mi
from
Evanston, IL
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
Evanston CCOP-NorthShore University HealthSystem
mi
from
Evanston, IL
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
Peoria Gynecologic Oncology
mi
from
Peoria, IL
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
Peoria Gynecologic Oncology
mi
from
Peoria, IL
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
University of Michigan University Hospital
mi
from
Ann Arbor, MI
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
University of Michigan University Hospital
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
Fox Chase Cancer Center
mi
from
Rockledge, PA
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
Fox Chase Cancer Center
mi
from
Rockledge, PA
Click here to add this to my saved trials
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated:  12/3/2015
Vancouver General Hospital
mi
from
Vancouver,
Ziv-aflibercept in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gynecologic Soft Tissue Sarcoma
A Phase II Study of VEGF-Trap in Recurrent or Metastatic Gynecologic Soft-Tissue Sarcomas
Status: Enrolling
Updated: 12/3/2015
Vancouver General Hospital
mi
from
Vancouver,
Click here to add this to my saved trials
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
Phase Ib Placebo-Controlled Trial of Diindolylmethane (BR-DIM) in the Study of the Modulation of Intermediate Endpoint Markers in Patients With Prostate Cancer Who Are Undergoing Prostatectomy
Status: Enrolling
Updated:  12/3/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Diindolylmethane in Treating Patients Undergoing Surgery for Stage I or Stage II Prostate Cancer
Phase Ib Placebo-Controlled Trial of Diindolylmethane (BR-DIM) in the Study of the Modulation of Intermediate Endpoint Markers in Patients With Prostate Cancer Who Are Undergoing Prostatectomy
Status: Enrolling
Updated: 12/3/2015
University of Wisconsin Hospital and Clinics
mi
from
Madison, WI
Click here to add this to my saved trials
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
Phase II Trial of Transcatheter Arterial Chemoembolization (TACE) Plus Oral Sorafenib (BAY 43-9006, Nexavar®) for Unresectable Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated:  12/3/2015
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Effectiveness and Safety Study of TACE Plus Oral Sorafenib for Unresectable HCC
Phase II Trial of Transcatheter Arterial Chemoembolization (TACE) Plus Oral Sorafenib (BAY 43-9006, Nexavar®) for Unresectable Hepatocellular Carcinoma (HCC)
Status: Enrolling
Updated: 12/3/2015
University of Pittsburgh Cancer Institute
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer
A Phase II Trial of ZD1839 (IRESSA®) for Patients With Recurrent or Metastatic Cancer of the Esophagus or Gastroesophageal Junction
Status: Enrolling
Updated:  12/4/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer
A Phase II Trial of ZD1839 (IRESSA®) for Patients With Recurrent or Metastatic Cancer of the Esophagus or Gastroesophageal Junction
Status: Enrolling
Updated: 12/4/2015
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Status: Enrolling
Updated:  12/4/2015
Viriginia Commonwealth University, Department of Radiation Oncology
mi
from
Richmond, VA
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Image-guided Adaptive Radiotherapy for Cervix Cancer: Patient Image Acquisition
Status: Enrolling
Updated: 12/4/2015
Viriginia Commonwealth University, Department of Radiation Oncology
mi
from
Richmond, VA
Click here to add this to my saved trials
Atkins Diet and Prostate Cancer Clinical Trial
Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men Initiating Androgen Deprivation Therapy For Prostate Cancer
Status: Enrolling
Updated:  12/4/2015
Greater Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Atkins Diet and Prostate Cancer Clinical Trial
Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men Initiating Androgen Deprivation Therapy For Prostate Cancer
Status: Enrolling
Updated: 12/4/2015
Greater Los Angeles VA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atkins Diet and Prostate Cancer Clinical Trial
Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men Initiating Androgen Deprivation Therapy For Prostate Cancer
Status: Enrolling
Updated:  12/4/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Atkins Diet and Prostate Cancer Clinical Trial
Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men Initiating Androgen Deprivation Therapy For Prostate Cancer
Status: Enrolling
Updated: 12/4/2015
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Atkins Diet and Prostate Cancer Clinical Trial
Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men Initiating Androgen Deprivation Therapy For Prostate Cancer
Status: Enrolling
Updated:  12/4/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Atkins Diet and Prostate Cancer Clinical Trial
Randomized Controlled Clinical Trial of Carbohydrate Restriction Among Men Initiating Androgen Deprivation Therapy For Prostate Cancer
Status: Enrolling
Updated: 12/4/2015
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer
A Phase II Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer
Status: Enrolling
Updated:  12/4/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
A Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer
A Phase II Study of Individualized Stereotactic Body Radiation Therapy (SBRT) for Intrahepatic Cancer
Status: Enrolling
Updated: 12/4/2015
University of Michigan Comprehensive Cancer Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated:  12/4/2015
Clinical Research Facility
mi
from
Aurora, CO
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated: 12/4/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated:  12/4/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated: 12/4/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated:  12/4/2015
Clinical Research Facility
mi
from
Tampa, FL
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated: 12/4/2015
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated:  12/4/2015
Clinical Research Facility
mi
from
Boston, MA
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated: 12/4/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated:  12/4/2015
Clinical Research Facility
mi
from
Cincinatti, OH
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated: 12/4/2015
Clinical Research Facility
mi
from
Cincinatti, OH
Click here to add this to my saved trials
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated:  12/4/2015
Clinical Research Facility
mi
from
Nashville, TN
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated: 12/4/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated:  12/4/2015
Clinical Research Facility
mi
from
San Antonio, TX
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated: 12/4/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated:  12/4/2015
Investigational Site Number 056004
mi
from
Brugge,
A Study of MLN0264 in Patients With Pancreatic Cancer
A Phase 2 Trial of MLN0264 in Previously Treated Patients With Advanced or Metastatic Pancreatic Adenocarcinoma Expressing Guanylyl Cyclase C (GCC)
Status: Enrolling
Updated: 12/4/2015
Investigational Site Number 056004
mi
from
Brugge,
Click here to add this to my saved trials
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Status: Enrolling
Updated:  12/4/2015
Washington University School of Medicine
mi
from
St. Louis, MO
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Status: Enrolling
Updated: 12/4/2015
Washington University School of Medicine
mi
from
St. Louis, MO
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Fountain Valley, CA
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Mission Hills, CA
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Santa Rosa, CA
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Santa Rosa, CA
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Vallejo, CA
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Vallejo, CA
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Whittier, CA
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Whittier, CA
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Danbury, CT
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Danbury, CT
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Greenwich, CT
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Greenwich, CT
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Fort Lauderdale, FL
Click here to add this to my saved trials
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated:  12/6/2015
Clinical Research Facility
mi
from
Chicago, IL
Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Randomized, Single-blind Study to Estimate the Effect of Patient Education on Reported Bone Pain in Breast Cancer Patients Receiving Chemotherapy and Pegfilgrastim
Status: Enrolling
Updated: 12/6/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials